A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The goal of this Phase 1 clinical research study is to find the highest safe dose of BIND-014
that can be given in the treatment of patients with advanced or metastatic cancer.